Cimzia® - Rheumatoid arthritis | UCB
Cimzia® (certolizumab pegol) is a tumor necrosis factor (TNF) blocker indicated in the US for the treatment of adults with moderately to severely active rheumatoid arthritis (RA). Warning: serious infections and malignancy. See full prescribing information for complete boxed warning.Explore further
About UCB - Specializing in Immunological Diseases - CIMZIA
WebWhat is CIMZIA? CIMZIA is a prescription medicine called a Tumor Necrosis Factor (TNF) blocker used in adults to: Lessen the signs and symptoms of moderately to severely …
CIMZIA[®] is the First and Only Biologic Approved in Europe with …
WebBrussels, Belgium – 5 August 2020 – UCB today announced that the European Medicines Agency (EMA) has approved a label extension for CIMZIA ® (certolizumab pegol) for use …
Cimzia®, the only PEGylated anti-TNF, approved in Europe and
WebBrussels, BELGIUM, 5 October, 2009 - 15:30 (CEST) - regulated information - UCB announced today that the European Commission (EC) approved Cimzia®, in …
CIMZIA® (certolizumab pegol) is Now the First and Only U.S. FDA …
WebBrussels, Belgium – 29 March 2019 – UCB, a global biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved …
- People also ask
Cimzia | UCB
WebCimzia | UCB. www.ucb-usa.com. Innovation. Products. Cimzia ® (certolizumab pegol) Full Prescribing Information. Medication Guide. View our Consumer Site. View our HCP Site. …
UCB's Cimzia® filed with EMEA for treatment of rheumatoid arthritis
WebBRUSSELS, BELGIUM - July 1st 2008 - 7:00 am CET - UCB today announced that a Marketing Authorisation Application (MAA) has been submitted to the European …
About UCB | CIMZIA® (certolizumab pegol)
WebToday, UCB is a truly global company with operations in over 40 countries; R&D facilities in the United States and Europe; Over 9,000 employees; As leaders in the creation of …
UCB: Early Data on Cimzia® from the WELCOME Study Show …
WebCimzia® is the first and only PEGylated anti-TNF-alpha (Tumor Necrosis Factor alpha). Cimzia® has a high affinity for human TNF-alpha, selectively neutralising the …
Certolizumab pegol - Wikipedia
WebCertolizumab pegol, sold under the brand name Cimzia, is a biopharmaceutical medication for the treatment of Crohn's disease, [2] [3] rheumatoid arthritis, psoriatic arthritis and …
